Progyny Inc
NASDAQ:PGNY

Watchlist Manager
Progyny Inc Logo
Progyny Inc
NASDAQ:PGNY
Watchlist
Price: 18.42 USD 0.22% Market Closed
Market Cap: $1.5B

P/S

1.2
Current
38%
Cheaper
vs 3-y average of 1.9

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
1.2
=
Market Cap
$1.5B
/
Revenue
$1.3B

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
1.2
=
Market Cap
$1.5B
/
Revenue
$1.3B

Valuation Scenarios

Progyny Inc is trading below its 3-year average

If P/S returns to its 3-Year Average (1.9), the stock would be worth $29.62 (61% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+197%
Average Upside
104%
Scenario P/S Value Implied Price Upside/Downside
Current Multiple 1.2 $18.42
0%
3-Year Average 1.9 $29.62
+61%
5-Year Average 3.5 $54.63
+197%
Industry Average 1.7 $27.48
+49%
Country Average 2.4 $38.36
+108%

Forward P/S
Today’s price vs future revenue

Today's Market Cap Revenue Forward P/S
$1.5B
/
Jan 2026
$1.3B
=
1.2
Current
$1.5B
/
Dec 2026
$1.4B
=
1
Forward
$1.5B
/
Dec 2027
$1.5B
=
1
Forward
$1.5B
/
Dec 2028
$1.7B
=
0.9
Forward
$1.5B
/
Dec 2029
$1.7B
=
0.9
Forward
$1.5B
/
Dec 2030
$1.7B
=
0.9
Forward
$1.5B
/
Dec 2031
$1.8B
=
0.8
Forward
$1.5B
/
Dec 2032
$1.9B
=
0.8
Forward

Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.

Peer Comparison

All Multiples
P/S
P/E
All Countries
Close
Market Cap P/S P/E
US
Progyny Inc
NASDAQ:PGNY
1.5B USD 1.2 25.8
US
UnitedHealth Group Inc
NYSE:UNH
332.9B USD 0.7 27.9
US
Anthem Inc
LSE:0HG8
96B USD 0.5 18.3
US
Elevance Health Inc
NYSE:ELV
78.8B USD 0.4 15.6
US
Humana Inc
NYSE:HUM
27.7B USD 0.2 24.7
US
Centene Corp
NYSE:CNC
24.4B USD 0.1 -4
US
Molina Healthcare Inc
NYSE:MOH
9.6B USD 0.2 54.3
US
Healthequity Inc
NASDAQ:HQY
6.9B USD 5.3 32.2
US
Magellan Health Inc
F:MAH1
2.2B EUR 0.5 8.5
BR
Odontoprev SA
BOVESPA:ODPV3
8B BRL 3.3 13.8
US
Clover Health Investments Corp
NASDAQ:CLOV
1.4B USD 0.7 -15.7
P/E Multiple
Earnings Growth PEG
US
Progyny Inc
NASDAQ:PGNY
Average P/E: 24.6
25.8
35%
0.7
US
UnitedHealth Group Inc
NYSE:UNH
27.9
22%
1.3
US
A
Anthem Inc
LSE:0HG8
18.3
10%
1.8
US
Elevance Health Inc
NYSE:ELV
15.6
10%
1.6
US
Humana Inc
NYSE:HUM
24.7
38%
0.6
US
Centene Corp
NYSE:CNC
Negative Multiple: -4 N/A N/A
US
Molina Healthcare Inc
NYSE:MOH
54.3
14%
3.9
US
Healthequity Inc
NASDAQ:HQY
32.2
32%
1
US
M
Magellan Health Inc
F:MAH1
8.5
N/A N/A
BR
Odontoprev SA
BOVESPA:ODPV3
13.8
4%
3.4
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -15.7 N/A N/A

Market Distribution

Lower than 71% of companies in the United States of America
Percentile
29th
Based on 11 520 companies
29th percentile
1.2
Low
0 — 1.2
Typical Range
1.2 — 4.1
High
4.1 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 1.2
Median 2.4
70th Percentile 4.1
Max 4 613 274.2

Progyny Inc
Glance View

In a world where the concept of family is continually evolving, Progyny Inc. emerges as a pioneer, reshaping the landscape of fertility and family-building benefits. Founded with a mission to offer comprehensive fertility solutions, the company leverages a unique combination of personalized concierge service and cutting-edge technology to meet the growing demand for reproductive health services. Progyny's role in the industry is substantial, providing a suite of tailored benefits that include fertility treatments, egg freezing, genetic testing, and support services. Through its proprietary Smart Cycle plan, Progyny stands apart by integrating these services into a single, streamlined benefits package, reducing complexities and elevating the experience for patients and employers alike. The heart of Progyny's business model lies in its collaboration with employers, offering them the opportunity to include comprehensive fertility benefits as part of their health packages. By doing so, Progyny opens the door for companies to attract and retain talent in a competitive workforce, ensuring employees have access to vital reproductive assistance. The company generates revenue by partnering with these employers, who pay for the fertility benefits as part of their employee health plans. This innovative approach not only ensures recurring income for Progyny but also aligns the company’s success with positive health outcomes for its clients. As more organizations recognize the value in supporting employees' family-building journeys, Progyny’s influence and relevance in the market continue to grow, reinforcing its standing as a leader in fertility solutions.

PGNY Intrinsic Value
37.84 USD
Undervaluation 51%
Intrinsic Value
Price $18.42
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett